PFE News 30.31 09/25/2014 05:31:42 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 30.31 $PFE

Final Glance: Pharmaceuticals companies
AP - Wed Sep 24, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:

Most active New York Stock Exchange-traded stocks
AP - Wed Sep 24, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

New FDA label bolsters safety case for Chantix
By MATTHEW PERRONE - AP - Wed Sep 24, 4:42PM CDT
WASHINGTON (AP) — New government-approved labeling on Pfizer's drug Chantix suggests that the anti-smoking medication may not carry the risks of suicidal behavior that first earned it the Food and Drug Administration's strongest warning more than five years ago.

Midday Glance: Pharmaceuticals companies
AP - Wed Sep 24, 12:21PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 1 p.m.:

Early Glance: Pharmaceuticals companies
AP - Wed Sep 24, 9:33AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Stock Market News for September 24, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 9:10AM CDT
Markets ended in the red zone for the third consecutive day as sluggish growth data from the Eurozone and air strikes in Syria offset China’s encouraging economic data

Stock Market Today: Futures Rise After Three Days of Losses
at The Street - Wed Sep 24, 8:05AM CDT
U.S. stock index futures are pointing to a higher open Wednesday, poised to break out of a losing streak after three sessions of declines.

Bull vs. Bear: MannKind Corporation Stock
Motley Fool Staff - Motley Fool - Wed Sep 24, 7:45AM CDT
MannKind   is a stock with tremendous promise -- and tremendous peril. And to up the stakes further, 19% of shares sold short according to data from S&P Capital IQ . But with an FDA approval finally under its belt and Sanofi  signed on as a...

Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics
PR Newswire - Wed Sep 24, 7:30AM CDT
On Tuesday, September 23, 2014, the NASDAQ Composite ended at 4,508.69, down 0.42%, the Dow Jones Industrial Average finished the day 0.68% lower at 17,055.87, and the S&P 500 closed at 1,982.77, down 0.58%. The losses were broad based as all the ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 742.96, down 0.58%, while the index has advanced 2.15% in the last one month. Investor-Edge has initiated coverage on the following equities: Pfizer Inc. (NYSE: PFE), BioDelivery Sciences International Inc. (NASDAQ: BDSI), Repros Therapeutics Inc. (NASDAQ: RPRX), Catalent Inc. (NYSE: CTLT), and Nektar Therapeutics (NASDAQ: NKTR). Free research on these five companies can be accessed at:

Pfizer
at Investor's Business Daily - Tue Sep 23, 5:45PM CDT
Pfizer (PFE) is exploring a bid for Actavis (ACT) and has approached officials at the generic-drug firm, but formal talks haven't started, according to Bloomberg sources. Pfizer shares fell 0.4% to 30.05. Actavis rose 2.2% to 240.85.

Stocks Finish Lower Among Takeover Rumors
at Investor's Business Daily - Tue Sep 23, 5:06PM CDT
Stocks finished the day down moderately, with the Nasdaq and the S&P 500 lower for the third straight day. Volume was running lighter than the previous day, according to preliminary figures. The Nasdaq was down 0.4%; the S&P 500 fell 0.6% and the Dow...

Stock Market Today: U.S. Stocks in 3-Day Losing Streak as U.S. Strikes Syria
at The Street - Tue Sep 23, 3:47PM CDT
The U.S. stocks fell for a third day as U.S. fighter jets attack the Islamic State militia in Syria.

Stocks Fall To Session Lows; Vipshop Bucks The Trend
at Investor's Business Daily - Tue Sep 23, 2:00PM CDT
Selling picked up the pace in the major averages in late-afternoon trading Tuesday. The Dow Jones industrial average fell 0.6%; the S&P 500 gave up 0.4% and the Nasdaq lost 0.3%. NYSE and Nasdaq volume was tracking about 5% to 10% lower than Monday's...

Why Actavis (ACT) Stock Is Higher Today
at The Street - Tue Sep 23, 1:36PM CDT
Pfizer( PFE) reportedly approached the company to express its interest in an acquisition, as Pfizer continues to explore ways to cut its tax rate and gain a new product pipeline.

US clampdown on tax maneuver leaves its mark
By The Associated Press - AP - Tue Sep 23, 12:10PM CDT
NEW YORK (AP) — A handful of big companies pursuing overseas mergers to lower their tax bills came under pressure Tuesday after the U.S. unveiled rules to discourage them.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 108

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 20

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 83

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 58

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 135

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 0

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 138

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading

Top 5 Most Recently Viewed Articles

MAGNA-TILES Unveils Exciting Rail Racers To Transform Play

Updated Category News Views 562

MAGNA-TILES Innovates Play with Rail Racers Launch First Fan-Made Invention Reimagines Ball Runs and Takes Magnetic Building to the Next Level MAGNA-TILES, America’s favorite magnetic building toy brand, has introduced an exciting innovation—the Rail Racers. This remarkable new product debuted at the American International Toy Fair, showcasing the creativity of the...

Continue Reading
Discover DDB Miner’s Innovative Approach to Bitcoin Mining

Updated Category News Views 167

Unlocking the Future of Bitcoin Mining DDB Miner, a forward-thinking Bitcoin mining entity, is making significant strides in the cryptocurrency industry. By emphasizing low-cost and efficient operations, DDB Miner is set on a path to redefine how Bitcoin is mined. Their latest operational update sheds light on impressive developments and ambitious plans that promise to...

Continue Reading
Warren Buffett Plans Charitable Giving with New CEO Transition

Updated Category News Views 217

Warren Buffett Speeds Up Charitable Contributions Warren Buffett recently announced that he will accelerate the distribution of his vast fortune, amounting to $149 billion, to his children's charitable foundations. This strategic decision aligns with the responsibilities he feels as a father, recognizing the increasing ages of his children. The Transition to Greg Abel As...

Continue Reading
Understanding the DeFi Technologies Class Action and Its Impact

Updated Category News Views 238

DeFi Technologies Class Action Explained Robbins LLP recently brought to light a class action lawsuit on behalf of investors who bought or acquired shares of DeFi Technologies Inc. (NASDAQ: DEFT). This action covers a specific timeframe, reflecting concerns over the company’s alleged misrepresentation of its business prospects. Investors seeking clarity on this...

Continue Reading
Alibaba's Robotics Innovation: Shaping the Future of AI Tech

Updated Category News Views 199

Alibaba's Bold Move into Robotics Alibaba Group (NYSE: BABA) has embarked on an exciting new venture by launching its own robotics team to compete in the rapidly advancing field of AI-powered physical products. This initiative reflects Alibaba's commitment to integrating artificial intelligence into everyday applications, transforming how technology interacts with the...

Continue Reading